Tharimmune Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	10.94	6.51	0	0.19	0.04
Cash & Cash Equivalents	10.94	6.51	0	0.19	0.04
Cash Growth	67.96%	149361.29%	-97.73%	401.17%	-
Other Current Assets	0.01	0.18	0.62	0.1	0
Total Current Assets	10.95	6.69	0.62	0.29	0.04
Total Assets	10.95	6.69	0.62	0.29	0.04
Accounts Payable	0.91	0.95	1.46	0.51	0.24
Current Debt	0	0	1.39	0.56	0.43
Other Current Liabilities	0.91	0.19	1.68	1.65	0.46
Total Current Liabilities	1.82	1.14	4.53	2.73	1.13
Long-Term Debt	0	0	0.77	1.29	0.53
Total Long-Term Liabilities	0	0	0.77	1.29	0.53
Total Liabilities	1.82	1.14	5.31	4.01	1.66
Total Debt	0	0	2.17	1.85	0.96
Debt Growth	-	-	17.03%	92.07%	-
Retained Earnings	-24.7	-15.38	-6.91	-4.7	-2.09
Shareholders' Equity	9.13	5.54	-4.68	-3.72	-1.62
Net Cash / Debt	10.94	6.51	-2.16	-1.66	-0.93
Net Cash / Debt Growth	67.96%	-	-	-	-
Net Cash Per Share	8.38	14.38	-8.50	-6.53	-6.16
Working Capital	9.13	5.54	-3.91	-2.43	-1.09
Book Value Per Share	7.00	12.25	-18.42	-14.64	-10.80

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).